Borrower record · Q2 2026
Laboratories Bidco LLC and Laboratories Topco
As filed by Ares Capital Corporation · period end 30 June 2026No sector — one filer, nothing to corroborate3 name variants under review
Ares Capital Corporation is the only BDC lending to Laboratories Bidco LLC and Laboratories Topco: $51.8m across seven positions at Q2 2026, marked at 79.4 cents. The filer carries it 21 cents below what it paid for it.
- Filed fair value
- $51.8m
- 7 funded positions
- Aggregate mark
- 79.4c
- covers 88% of positions with a filed cost
- Median spread
- 175bp
- over SOFR, 6 tranches
- Maturities to
- 2029
- one date, 1 July 2029
- Periods on record
- 5
- Q2 2025 → Q2 2026
How this total is counted
- Every figure above is the sum of 7 funded positions filed by Ares Capital Corporation, each one cited below.
- Counted from the Q2 2026 filings imported for this build, the latest of them filed 20 August 2026. A schedule filed after that date is not in these figures and will appear when the property is rebuilt.
- 1 filed position carries no positive fair value — unfunded or written off — and is outside every figure above.
- 3 filed name variants are under review against this borrower. Until they are resolved, anything filed under those names is counted nowhere on this page.
Pricing as filed
6 floating tranches · SOFRBar length is the number of tranches filed at that spread. The accented row holds the median tranche.
177bp weighted by fair value, across the same 6 tranches.
Capital structure
First-Lien Senior Secured, on all 7 positions whose seniority a filer disclosed.
Rate structure
Floating, on all 7 positions whose interest type a filer disclosed.
Maturity profile
all 7 funded positions dated3.0 years to maturity, weighted by fair value across the 7 dated positions.
Filed over time
5 periods · aggregate onlyFiled fair value
Aggregate marknot to zero
Q2 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026 — every filer reporting the borrower at each period, aggregated. No lender is separated out at any period.
Credit flags
The filer reports no position on non-accrual, and no filed tranche pays in kind.
Not in the filings
- No sector, and there cannot be one: the test needs two filers to agree and only one filed a label.
- No filed cost on 13% of positions, which the aggregate mark therefore excludes.
- No index floor filed on any tranche.
Sign up for free
Tell me when this changes.
One lender reports Laboratories Bidco LLC and Laboratories Topco today. We will email you when a second one does, when Ares Capital Corporation's mark moves, or when the position leaves the schedule.
- A second BDC reports this borrower
- The filed mark moves by more than two cents
- A position goes on non-accrual or starts paying in kind
- The borrower drops out of the schedule entirely
Every filing behind this page
1 filer · Q2 2026| Filer | CIK | Form | Period | Filed | Accession |
|---|---|---|---|---|---|
| Ares Capital Corporation (ARCC) | 0001287750 | 10-Q | 2026-06-30 | 2026-07-29 | 0001628280-26-050307 |
Related borrowers
Same lender